MedTrace Logo

Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals

NCT04753242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2021-10-28

No results posted yet for this study

Summary

Heads of all psychosomatic, psychiatric and psychological consultation and liaison (C\&L) services in acute care hospitals across all participating countries will be contacted and asked to participate in this international cross-sectional online survey. The survey consists of questions about care structures and their utilisation that psychosomatic, psychiatric and psychological C\&L services have established in acute hospitals in the context of the COVID 19 pandemic.

Conditions

  • Covid-19
  • COVID-19 Related Psychosocial Burden

Interventions

OTHER

Online survey questionnaire

Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding psychosocial care structures that psychosocial C\&L services have established in acute hospitals in the context of the COVID-19 pandemic, the implementation and use of COVID-19-related services for patients, relatives and staff, special challenges, as well as needs and wishes for the future. Thereby the survey is aiming at the creation of a data basis for improving the structural and process quality of psychosocial care services through psychosocial C\&L services in the context of pandemics, especially the COVID-19 pandemic.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Rainer Schaefert, Prof. Dr. med. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-08
Primary Completion
2021-10-03
Completion
2021-10-03

Countries

  • Austria
  • Belgium
  • Canada
  • Finland
  • France
  • Germany
  • Greece
  • Iran
  • Ireland
  • Italy
  • Norway
  • Poland
  • Portugal
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04753242 on ClinicalTrials.gov